Dr. Elia J. Duh, MD

Dr. Duh practices at Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System.

Dr. Duh's NPI, 1114974318, was assigned on May 31, 2006. Dr. Duh graduated from Harvard Medical School in 1993. Dr. Duh holds Maryland license D55253.

Dr. Duh's primary practice is Johns Hopkins Bayview Medical Center, at 4940 Eastern Avenue, Baltimore, MD 21224 in Baltimore City. The practice phone is (410) 550-0123.

Dr. Duh's primary practice is Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System. Dr. Duh is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Duh to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Duh practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Duh's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Duh is licensed in Maryland.

CMS data shows 1,239 Medicare services from Dr. Duh across 6 procedure codes in 2024, for 199 Medicare patients. Medicare paid $50,231 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 199 Medicare patients who saw Dr. Duh in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Duh's median patient age at 76, with 56% women.

In 2024, Dr. Duh wrote 52 Medicare Part D claims for 17 patients. 83% of them were for generic drugs. CMS names the drug for 31 of them, across 2 drugs with 11 or more claims each, at $189 in total drug cost. In 2023, CMS named 48 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Duh for performance year 2024, reported as part of a group.

Dmand AI links 53 papers to Dr. Duh, published from 2011 to 2025. 2015 was the busiest year, with 6. The most frequent topics are NF-E2-Related Factor 2, Diabetic Retinopathy and Retina. Dr. Duh has published most often in Invest Ophthalmol Vis Sci. Dr. Duh's most frequent co-authors are Sharon Solomon, MD, Jennifer K. Sun, MD and Charles Clifton Wykoff, MD, PhD.

Dmand AI links Dr. Duh to 1 clinical trial. Conditions studied include Conjunctivitis, Viral and Eye Infections, Viral.

CMS Open Payments shows 1 general payment to Dr. Duh from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $108.

Dr. Duh graduated from Harvard Medical School in 1993.